Sarcoma Alliance,
A clinical trial for patients with advanced gastrointestinal stroll tumor (GIST) compared the targeted treatment ripretinib to…
Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE
Overview of attention for article published in Journal of Clinical Oncology, May 2025
Altmetric Badge
About this Attention Score
-
Good Attention Score compared to outputs of the same age (72nd percentile)
Readers on
- mendeley
- 10 Mendeley